PharmaCorp Rx Inc. (TSXV:PCRX)
Canada
· Delayed Price · Currency is CAD 0.415
0.00 (0.00%)
At close: Dec 5, 2025
PharmaCorp Rx Market Cap
PharmaCorp Rx has a market cap or net worth of CAD 69.27 million as of December 5, 2025. Its market cap has decreased by -13.12% in one year.
Market Cap
69.27M
Enterprise Value
68.80M
Revenue
17.60M
Ranking
n/a
PE Ratio
256.97
Stock Price
0.42
Market Cap Chart
Since September 29, 2022, PharmaCorp Rx's market cap has increased from 2.40M to 69.27M, an increase of 2,786.44%. That is a compound annual growth rate of 187.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 69.27M | 9.37% |
| Dec 31, 2024 | 63.34M | 427.83% |
| Dec 30, 2022 | 12.00M | 400.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.87B |
| Green Thumb Industries | 2.22B |
| dentalcorp Holdings | 2.18B |
| Sienna Senior Living | 1.91B |
| Extendicare | 1.85B |
| Trulieve Cannabis | 1.48B |
| Cronos Group | 1.34B |
| WELL Health Technologies | 1.01B |